Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;15(9):983-985.
doi: 10.1016/j.jiph.2022.07.013. Epub 2022 Jul 28.

Immediate reinfection with Omicron variant after clearance of a previous SARS-CoV-2 infection

Affiliations

Immediate reinfection with Omicron variant after clearance of a previous SARS-CoV-2 infection

Antonella Mencacci et al. J Infect Public Health. 2022 Sep.

Abstract

SARS-CoV-2 Omicron variant is spreading worldwide, causing unprecedented epidemic peaks due to its transmissibility and immune evasion. We searched in the archive of the Regional Microbiology Laboratory (Umbria, Italy) for immediate reinfection (i.e. infection occurring 25-60 days from primary infection) among 454,764 RT-PCR tests from 261,217 individuals. Lineage heterogeneity was assessed by S gene target failure phenomenon or whole genome sequencing. We found that BA.1 Omicron variant may cause immediate reinfection of patients just recovered from Delta infection. Immediate reinfection was not observed for any other combination of variants, including Delta over Alpha variant and BA.2 over BA.1 Omicron lineage.

Keywords: COVID-19; Delta; Omicron; Reinfection; SARS-CoV-2.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Frequency of SARS-CoV-2 infection and Omicron BA.1 lineage reinfection in Umbria. Panel A, incidence of SARS-CoV-2 infection with circulating variants from the National Flash Surveys. These Surveys of the Italian Institute of Health are carried out every 2 weeks by WGS on a random sample of cases. Panel B, features of the four cases of reinfection identified during the October 2021 - January 2022 period, corresponding to the surge of Omicron BA.1 cases.

References

    1. Pulliam J.R.C., van Schalkwyk C., Govender N., von Gottberg A., Cohen C., Groome M.J., et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science. 2022;376 - PMC - PubMed
    1. Micheli V., Bracchitta F., Rizzo A., Mancon A., Mileto D., Lombardi A., et al. First identification of the new SARS-CoV-2 Omicron variant (B.1.1.529) in Italy. Clin Infect Dis. 2022 - PMC - PubMed
    1. Tillett R.L., Sevinsky J.R., Hartley P.D., Kerwin H., Crawford N., Gorzalski A., et al. Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet Infect Dis. 2021;21:52–58. - PMC - PubMed
    1. Hansen C.H., Michlmayr D., Gubbels S.M., Mølbak K., Ethelberg S. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. Lancet. 2021;397:1204–1212. - PMC - PubMed
    1. Lumley S.F., O’Donnell D., Stoesser N.E., Matthews P.C., Howarth A., Hatch S.B., et al. Antibody status and incidence of SARS-CoV-2 infection in health care workers. N Engl J Med. 2021;384:533–540. - PMC - PubMed

Supplementary concepts